Ubs Group Ag Enzo Biochem Inc Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

A detailed history of Ubs Group Ag transactions in Enzo Biochem Inc stock. As of the latest transaction made, Ubs Group Ag holds 278 shares of ENZ stock, worth $205. This represents 0.0% of its overall portfolio holdings.

Number of Shares
278
Previous 723 61.55%
Holding current value
$205
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1.04 - $1.18 $462 - $525
-445 Reduced 61.55%
278 $0
Q2 2024

Aug 13, 2024
BUY
$1.04 - $1.28 $462 - $569
445 Added 160.07%
723 $0
Q1 2024

May 13, 2024
SELL
$1.21 - $1.5 $1,931 - $2,394
-1,596 Reduced 85.17%
278 $0
Q4 2023

Feb 09, 2024
BUY
$1.21 - $1.44 $2,267 - $2,698
1,874 New
1,874 $2,000
Q2 2023

Aug 11, 2023
BUY
$1.84 - $2.66 $1,138 - $1,646
619 New
619 $1,000
Q4 2022

Feb 08, 2023
BUY
$1.16 - $2.42 $1,569 - $3,274
1,353 New
1,353 $1,000
Q1 2022

May 16, 2022
SELL
$2.9 - $3.47 $8,059 - $9,643
-2,779 Reduced 86.74%
425 $1,000
Q4 2021

Feb 14, 2022
SELL
$3.17 - $4.09 $3,677 - $4,744
-1,160 Reduced 26.58%
3,204 $10,000
Q3 2021

Nov 15, 2021
BUY
$3.01 - $3.77 $9,442 - $11,826
3,137 Added 255.66%
4,364 $16,000
Q2 2021

Aug 13, 2021
SELL
$2.86 - $3.61 $22,039 - $27,818
-7,706 Reduced 86.26%
1,227 $4,000
Q1 2021

May 12, 2021
SELL
$2.61 - $4.08 $10,635 - $16,626
-4,075 Reduced 31.33%
8,933 $30,000
Q4 2020

Feb 11, 2021
BUY
$1.82 - $2.61 $12,144 - $17,416
6,673 Added 105.34%
13,008 $33,000
Q3 2020

Nov 12, 2020
SELL
$2.02 - $3.02 $17,493 - $26,153
-8,660 Reduced 57.75%
6,335 $13,000
Q2 2020

Jul 31, 2020
SELL
$2.12 - $3.22 $28,952 - $43,975
-13,657 Reduced 47.67%
14,995 $34,000
Q1 2020

May 01, 2020
SELL
$1.82 - $3.87 $53,830 - $114,462
-29,577 Reduced 50.79%
28,652 $72,000
Q4 2019

Feb 14, 2020
BUY
$2.57 - $3.68 $23,877 - $34,190
9,291 Added 18.99%
58,229 $153,000
Q3 2019

Nov 14, 2019
BUY
$3.01 - $4.0 $84,701 - $112,560
28,140 Added 135.3%
48,938 $176,000
Q2 2019

Aug 14, 2019
BUY
$2.79 - $4.31 $17,878 - $27,618
6,408 Added 44.53%
20,798 $70,000
Q1 2019

May 14, 2019
SELL
$2.54 - $4.02 $48,239 - $76,347
-18,992 Reduced 56.89%
14,390 $39,000
Q4 2018

Feb 14, 2019
BUY
$2.46 - $4.2 $20,587 - $35,149
8,369 Added 33.46%
33,382 $93,000
Q3 2018

Nov 14, 2018
BUY
$3.81 - $5.53 $7,673 - $11,137
2,014 Added 8.76%
25,013 $103,000
Q2 2018

Aug 14, 2018
BUY
$5.06 - $6.78 $36,953 - $49,514
7,303 Added 46.53%
22,999 $119,000
Q1 2018

May 15, 2018
SELL
$5.43 - $8.36 $29,446 - $45,336
-5,423 Reduced 25.68%
15,696 $86,000
Q4 2017

Feb 14, 2018
SELL
$8.15 - $10.55 $219,887 - $284,639
-26,980 Reduced 56.09%
21,119 $172,000
Q3 2017

Nov 14, 2017
BUY
$10.45 - $11.44 $13,814 - $15,123
1,322 Added 2.83%
48,099 $504,000
Q2 2017

Aug 14, 2017
SELL
N/A
-538 Reduced 1.14%
46,777 $516,000
Q1 2017

Nov 14, 2017
BUY
N/A
47,315
47,315 $396,000

Others Institutions Holding ENZ

# of Institutions
48
Shares Held
15.5M
Call Options Held
2.3K
Put Options Held
0
View Full List

About ENZO BIOCHEM INC

ENZ Quotes by TradingView
  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $36.1M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email